Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYECO GROUP LTD Capital/Financing Update 2011

Mar 24, 2011

65304_rns_2011-03-24_02d73048-a4a2-4b0f-ae4e-a42b8c398887.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [190 x 120] intentionally omitted <==

TO: COMPANY ANNOUNCEMENTS OFFICE ASX LIMITED

DATE: 25[th] March 2011

CARDIA’S ADR TRADING TO BEGIN ON OTC MARKET

Cardia Bioplastics, Ltd, (ASX: CNN; OTCQX: CDRBY) a global developer, manufacturer and marketer of sustainable resins and finished products derived from renewable resources, is pleased to announce that its American Depositary Receipts will begin trading on 25[th] March 2011- U.S.A Time on the OTC market’s prestigious tier,OTCQX International. Investors can find current financial disclosure and real-time level 2 quotes for Cardia on www.otcqx.com and www.otcmarkets.com.

Viriathus Capital LLC will be serving as Cardia Bioplastic’s exclusive OTCQX Advisor and BNY Mellon (Bank of New York Mellon) will serve as Principle American Liaison (“PAL”).

Mr. Pat Volpe, Executive Chairman of Cardia Bioplastics commented, “We are extremely pleased to be joining the OTCQX, and to be amongst some of the most prestigious international companies also trading in this marketplace. Joining the premier tier of the OTC offers many of the benefits of listing on a U.S. exchange without the associated high costs and legal burden typically required. The dual listing on the ASX in Australia and on the OTC-QX in the U.S.A. will provide the company with more exposure to U.S and other global investors who can trade the Cardia ADR’s without cross country and cross currency issues creating potential liquidity for Cardia’s securities in the U.S.A. With the assistance of Viriathus, we look forward to increasing our visibility and exposure to the largest capital market in the world.”

“Viriathus is very excited to be working with Cardia Bioplastics,” said David Batista, Senior Managing Director of Viriathus.“We believe that with our strong track record of bridging the gap between ASX listed companies and U.S. investors, driven by our sponsorship platform consisting of investment banking, equity research and financial marketing services, Viriathus is uniquely positioned to help elevate Cardia’s profile within the broad U.S. investor community.“

Pat Volpe Chairman

About Cardia Bioplastics Ltd.

Cardia Bioplastics, Ltd. (ASX: CNN; OTCQX: CDRBY) trades in the United States on the OTCQX International under the symbol “CDRBY”, where each ADR represents 500 ordinary shares. Cardia Bioplastics is a global developer, manufacturer and marketer of

==> picture [511 x 44] intentionally omitted <==

sustainable resins and finished products derived from renewable resources based in Australia.The Company develops, manufactures and markets a range of sustainable bioplastics to the packaging and plastics products industries.The Company's product materials are suitable for injection moulding, blow moulding, extrusion, film and coating applications. Co.'s product range includes biohybrid and compostable resins.The Company maintains offices in Europe and the Americas, and a network of distributors across Australia, the Americas, Europe and Asia. The Company's operations are organized along three segments: Cardia biohybrid; Cardia compostable; and Cardia bioproducts.

About Viriathus Capital LLC

Viriathus Capital LLC, is the investment banking subsidiary of Viriathus Holdings LLC which is part of a multifaceted boutique organization dedicated to providing emerging growth companies, worldwide, with a sponsorship platform supported by premier investment banking services, exceptional and credible research as well as consulting services that develop and maintain institutional support. Viriathus Capital provides the highest quality of investment banking and financial advisory services, encompassing corporate finance, strategic advisory, equity advisory, debt advisory, private security sales and capital introduction. For more information about Viriathus, visit www.viriathus.com.

About OTCQX

The OTCQX marketplace is the premier tier of the US OTC market. Investor-focused companies use the quality-controlled OTCQX platform to offer investors transparent trading, superior information, and easy access through their regulated US broker-dealers. The innovative OTCQX platform offers companies and their shareholders a level of marketplace services formerly available only on a US stock exchange.For more information and to view a full list of OTCQX companies, visit www.otcqx.com